OS THERAPIES INCORPORATED

Historical 13F Holders

Symbol
OSTX
CUSIP
68764Y207
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Every filing for 68764Y207 since 12/18/2024, newest first.

Filer % of Class Filed
Shalom Auerbach 13D/A Amendment 4
8.5% 8/18/2025
Event 7/29/2025
Thomas A. Satterfield, Jr. 13G/A Amendment 2 9.4% 8/13/2025
Event 6/30/2025
Shalom Auerbach 13D/A Amendment 3
9.9% 5/9/2025
Event 5/7/2025
Ayala Pharmaceuticals, Inc. 13G 10.0% 4/16/2025
Event 4/9/2025
Shalom Auerbach 13D/A Amendment 2
12.9% 3/12/2025
Event 7/31/2024
Shalom Auerbach 13D/A Amendment 1
12.9% 2/28/2025
Event 2/27/2025
Thomas A. Satterfield, Jr. 13G/A Amendment 1 5.9% 2/12/2025
Event 12/31/2024
Shalom Auerbach 13D
11.9% 1/17/2025
Event 7/31/2024

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 5 283 k $452 k
2026 Q2 30 3.15 M $5.98 M
2026 Q1 30 2.90 M $4.09 M
2025 Q4 26 1.78 M $2.49 M
2025 Q3 26 1.56 M $3.07 M
2025 Q2 15 605 k $1.14 M
2025 Q1 8 390 k $601 k
2024 Q4 7 146 k $624 k
2024 Q3 8 160 k $448 k